Analyst Recommendations

RBC Capital analyst issues OUTPERFORM recommendation for CVE on February 18, 2026 01:34PM ET. The previous analyst recommendation was Outperform.CVE was trading at $21.58 at issue of the...

February 18, 2026   CVE 2.11%

Stephens analyst issues OVERWEIGHT recommendation for EQT on February 18, 2026 11:40AM ET. The previous analyst recommendation was Overweight.EQT was trading at $57.75 at issue of the analyst...

February 18, 2026   EQT 0.93%

Barclays analyst issues OVERWEIGHT recommendation for MDT on February 18, 2026 10:12AM ET. The previous analyst recommendation was Overweight.MDT was trading at $96.41 at issue of the analyst...

February 18, 2026   MDT -0.17%

Barclays analyst issues OVERWEIGHT recommendation for PCG on February 18, 2026 10:14AM ET. The previous analyst recommendation was Overweight.PCG was trading at $18.02 at issue of the analyst...

February 18, 2026   PCG -1.50%

Jefferies analyst issues HOLD recommendation for ET on February 18, 2026 09:40AM ET. The previous analyst recommendation was Hold.ET was trading at $18.61 at issue of the analyst...

February 18, 2026   ET 2.34%

Morgan Stanley analyst issues OVERWEIGHT recommendation for MT on February 17, 2026 06:05PM ET. The previous analyst recommendation was Overweight.MT was trading at $64.065 at issue of the...

February 17, 2026   MT 1.77%

Needham analyst issues BUY recommendation for MU on February 17, 2026 02:58PM ET. The previous analyst recommendation was Buy.MU was trading at $411.56 at issue of the analyst...

February 17, 2026   MU 2.96%

Oppenheimer analyst issues OUTPERFORM recommendation for DKNG on February 17, 2026 01:08PM ET. The previous analyst recommendation was Outperform.DKNG was trading at $21.76 at issue of the analyst...

February 17, 2026   DKNG 4.65%

RBC Capital analyst issues OUTPERFORM recommendation for CCJ on February 17, 2026 01:34PM ET. The previous analyst recommendation was Outperform.CCJ was trading at $112.9 at issue of the...

February 17, 2026   CCJ 3.71%

UBS analyst issues NEUTRAL recommendation for CRM on February 17, 2026 01:49PM ET. The previous analyst recommendation was Neutral.CRM was trading at $189.72 at issue of the analyst...

February 17, 2026   CRM 0.96%